Sculptra® Aesthetic

Product Details

Sculptra<sup><small>®</small></sup> Aesthetic

FDA Approval Date

July 2009

Approved Use

Treatment of lipoatrophy (loss of facial fat) in HIV positive individuals. Correction of shallow to deep nasolabial fold (smile lines) contour deficiencies and other facial wrinkles.

Duration

25 months or more

Side Effects

Reportedly bruising, swelling, redness

Adverse Outcomes

May be visible or felt. In rare cases may develop nodules (small bumps beneath the skin)

Return to full product listing.